This message contains images. If you don't see images, click here to view.
Advertise in this news brief.




  Mobile version   RSS   Subscribe   Unsubscribe   Archive   Media Kit January 14, 2015



















Not an AzPA member?

Not an AzPA member? Join the only statewide association representing all pharmacy professionals in all pharmacy practice settings.



Stay connected with AzPA!

 Like us on Facebook

 Follow us on Twitter

 




AREA & ASSOCIATION NEWS

Coventry/Aetna Part D —Temporary processing fix effective TODAY
AzPA
National Community Pharmacists Association continues to focus on the current Medicare Part D issues surrounding 2015 Aetna Part D plans and the negative impact on patients and pharmacies.

On Friday, NCPA strongly recommended to CMS that they work with Aetna to implement a temporary processing fix for non-network pharmacies (utilizing an existing Aetna contract already in place with most pharmacies) for patients and pharmacies that have experienced problems with the network pharmacy confusion with certain 2015 Aetna Part D plans. In addition we advised that the fix be retroactive to Jan. 1, 2015, to allow for processing of claims by non-network pharmacies that may have already been filled but not adjudicated since Jan. 1 in efforts to assist patients.

The attached Aetna communication appears to outline just such a plan effective today. It states: "If your pharmacy is a Non Participating provider in the Aetna/Coventry 2015 Standard or Standard Preferred networks, you will be able to TEMPORARILY process claims for certain Coventry Medicare Part D members at Premier Preferred in-network reimbursement rates starting Monday, Jan. 12, 2015.

The effective date of this temporary transition will be Jan. 1, 2015."

Though this is a temporary solution, NCPA believes that this is a very positive step towards helping patients receive the medications they need while alleviating the immediate problems for most pharmacies.

NCPA has also inquired as to whether there is a similar process being developed to address any Aetna Part D patients/claims that are processed by CVSCaremark, however, as of this writing we have not received any information on whether that is pending.

Download more information here.
   Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article


2 DAYS LEFT TO SAVE: Anticoagulation Certificate Program & Southwestern Clinical Pharmacy Seminar
AzPA
This February, join AzPA in Tucson for your professional development. Friday, Feb. 20 become certified in anticoagulation management. Then Saturday-Sunday attend the Southwestern Clinical for sessions on drug updates, medication adherence, pharmacy law, infectious diseases and more. But hurry. Early bird pricing for both events end Jan. 16.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


PRODUCT SHOWCASE
  Be a part of Innovation!

Banner Pharmacy Services will be recognized nationally as a clinical leader and trusted partner in providing innovative pharmacy services and coordinated patient care through convenient access and improved medication outcomes across the continuum.

Click here for Leadership opportunities

Contact: shaun.gustafson@bannerhealth.com
 


CMS updates pneumococcal vaccination reimbursement policy
AzPA

Effective date: Sept. 19, 2014
  *Unless otherwise specified, the effective date is the date of service.
Implementation date: Feb. 2, 2015

I. GENERAL INFORMATION
A. Background: Medicare Part B covers certain vaccinations including pneumococcal vaccines. Generally, pneumococcal vaccine was covered once in a beneficiary's lifetime, with revaccinations covered for those at highest risk if 5 years have passed since the last vaccination, or if the beneficiary's vaccination history was unknown.

The ACIP recently updated its guidelines regarding pneumococcal vaccines. The ACIP recommends administration of two different pneumococcal vaccinations.

B. Policy: CMS is updating the Medicare coverage requirements to align with the updated ACIP recommendations. An initial pneumococcal vaccine may be administered to all Medicare beneficiaries who have never received a pneumococcal vaccine under Medicare Part B. A different, second pneumococcal vaccine may be administered 1 year after the first vaccine was administered (i.e., 11 full months have passed following the month in which the last pneumococcal vaccine was administered).

Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Planning on attending the Southwestern Clinical Pharmacy Seminar?
AzPA
Book your hotel room at the JW Marriott ASAP. There are still a few AzPA designated rooms available. Get your conference rate room today!
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


UPCOMING EVENTS


Date Event
Jan. 29 Pharmacy Day at the Capitol
Feb. 20 Anticoagulation Certificate Program 2015
Feb. 21-22 Southwestern Clinical Pharmacy Seminar
April 25 Women's Health Certificate Program
June 25 Psychiatric Certificate Program
June 25 Diabetes Care Certificate Program
June 25 Immunization Certificate Program
June 25 Medication Therapy Management Certificate Program
June 26-28 AzPA Annual Convention
Sept. 25 Anticoagulation Certificate Program
Sept. 25 Women's Health Certificate Program
Sept. 25 Immunization Certificate Program
Sept. 26 Fall Conference


Click here for a full event list.




PHARMACY UPDATES


Government seizes $18 million from owners of pharmacy tied to meningitis outbreak
Reuters via Fox News
U.S. officials said they seized $18 million from the owners of a defunct Massachusetts compounding pharmacy tied to a national 2012 meningitis outbreak that killed at least 64 people and sickened about 750. The funds were seized from 13 financial institutions, including from accounts held by the majority shareholders of the pharmacy, the New England Compounding Center, as well as its head pharmacist, Barry Cadden, who held a minority stake, federal prosecutors in Boston said.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Are independent pharmacies really that profitable?
By Jason Poquette
Every year I look forward to reading Dr. Adam Fein's analysis of the profitability of independent pharmacies in the U.S. He is a respected industry analyst and writes well-researched posts on his blog, Drug Channels, which covers a wide range of drug distribution topics. The data revealed this year (for 2013) suggests that the average owner of an independent pharmacy earns $247,000 per year. But is the data telling the whole story? Does it really reflect the real-life income of most pharmacy owners today?
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Traveling with chronic illnesses, especially diabetes
By Cynthia Sheppard Solomon
Whether a patient has diabetes or some other chronic illness, being prepared can make a trip much more pleasant. For example, carrying a personal health record complete with lists of prescriptions, dietary supplements and other personal information can make a huge difference in how enjoyable a trip can be, should something surprising occur. Are your patients comfortable speaking with you about upcoming travels? Have you ever forgotten your meds when you are away from home? Can you relate to their struggles?
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Pharmacy board recommends cannabis oil be schedule II
WHO-TV
The Iowa Board of Pharmacy met to discuss a request to reclassify marijuana. Right now marijuana is listed in Iowa code as a schedule I, or a drug with no proven medical use. Carl Olsen of Des Moines petitioned the board last July asking them to classify it as a schedule II, or drug with some accepted medical treatment.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Changing health care world impacts pharmacist's role, responsibilities
Houston Chronicle
The changing world of pharmacies is impacting the role of a pharmacist and their duties, making the job ever more challenging and diverse. Traditional community pharmacy settings still provide a home for pharmacists, but new opportunities continue to grow with hospitals and clinics. The role has begun to evolve from filling prescriptions, verifying the correct dosage and ensuring no major drug interactions exist, to also now dispensing flu shots, as well as meningitis and shingles vaccines.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Extreme obesity calls for individualized medication
Medical News Today
Doctors and pharmacists often do not take obesity into account when prescribing medication. For this, more insight into the influence of obesity on the distribution and elimination of drugs is of the utmost importance. This is emphasized by Catherijne Knibbe in the most recent issue of the Annual Review of Pharmacology and Toxicology.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Pharmacy blood pressure monitoring kiosks comparable to ambulatory assessment
Pharmacy Times
Results of a peer-reviewed clinical study support the use of pharmacy-based PharmaSmart kiosks in assessing hypertension, as the routine blood pressure testing on the kiosks was deemed comparable to daytime ambulatory blood pressure measurement, the current clinical gold standard.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Miss an issue of the AzPA Pharmacy Flash? Click here to visit the AzPA Pharmacy Flash archive page.


FDA OKs new anti-clotting drug for heart rhythm disorder
HealthDay News
A new anti-clotting drug to reduce the risk of dangerous blood clots and strokes in people with a type of heart rhythm disorder has been approved by the FDA. Savaysa is approved to treat people with atrial fibrillation that's not caused by a heart valve problem. Atrial fibrillation — the most common type of heart rhythm disorder — increases the risk of developing blood clots that can travel to the brain and cause a stroke.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Adverse outcomes unlikely after measles, mumps vaccination
Pharmacy Times
The seven main adverse outcomes associated with two common childhood immunizations are highly unlikely to occur following vaccine administration, according to the results of a long-term study published online Jan. 5 in Pediatrics.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


 

AzPA Pharmacy Flash
Colby Horton, Vice President of Publishing, 469.420.2601
Download media kit

Danielle Wegert, Assistant Executive Editor, 469.420.2696   
Contribute news

Disclaimer: The AzPA Pharmacy Flash is a weekly roundup of articles of interest to pharmacists and pharmacy professionals. This email may contain an advertisement of AzPA and/or third party products and services. Opinions expressed in these articles do not necessarily reflect the views of AzPA or its advertising partners. The AzPA Pharmacy Flash is compiled by MultiBriefs, a division of MultiView, Inc. Factual errors are the responsibility of the listed publication.

This edition of the AzPA Pharmacy Flash was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here — it's free!
Recent issues
Jan. 7, 2015
Dec. 31, 2014
Dec. 24, 2014
Dec. 17, 2014



7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063